{"id":"W2800810996","doi":"10.1002/hon.2513","title":"Management of newly diagnosed high‐risk and intermediate‐risk follicular lymphoma with <sup>90</sup>Y ibritumomab tiuxetan in a phase II study","year":2018,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Spectrum Pharmaceuticals","keywords":"Medicine; Ibritumomab tiuxetan; Follicular lymphoma; Internal medicine; Rituximab; International Prognostic Index; Oncology; Gastroenterology; Immunotherapy; Vincristine; Lymphoma; Cyclophosphamide; Radioimmunotherapy; Surgery; Immunology; Chemotherapy; Cancer; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00135174,0.0006573209,0.0009118028,0.0001502202,0.0002270312,0.0005074111,0.0005806988,0.0004936457,0.0007902431],"category_scores_gemma":[0.0005161092,0.0003147223,0.0008155043,0.0001507139,0.0004964771,0.0004255035,0.0002068903,0.001281153,0.0002336956],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006368494,"about_ca_system_score_gemma":0.0006935208,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008251081,"about_ca_topic_score_gemma":0.001375811,"domain_scores_codex":[0.9996831,0.0001636115,0.00001834504,0.00003014921,0.0000310699,0.00007369302],"domain_scores_gemma":[0.9995814,0.00006720657,0.00006163834,0.00003689407,0.00002216244,0.0002307277],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.523706,0.1127483,0.07410716,0.0007573535,0.001805879,0.001077387,0.0007996855,0.002401278,0.05603187,0.0003357803,0.002172734,0.2240566],"study_design_scores_gemma":[0.2374296,0.6660327,0.08545585,0.00004482397,0.0005980115,0.001191485,0.0001611952,0.001481941,0.004430716,0.0001645211,0.002985459,0.00002373422],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986163,0.0006276308,0.0001103054,0.00006814505,0.00001716682,0.000219726,0.0000320671,0.000007995731,0.0003006018],"genre_scores_gemma":[0.9976902,0.0006449909,0.0004493717,0.0001953278,0.00006336257,0.0003689634,0.0002353529,0.000003828664,0.0003485703],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00135174,"threshold_uncertainty_score":0.007148802,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01419383430954533,"score_gpt":0.2984657552718471,"score_spread":0.2842719209623017,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}